Souvien Therapeutics Company

Souvien Therapeutics is developing novel therapeutics to modulate critical epigenetic mechanisms associated with neurodegeneration.


Investors

Total Funding: 3500000
Headquarters: Salt Lake City, Utah, United States
Estimated Revenue: $10M to $50M
Last Funding Type: Venture - Series Unknown
Technology: Anti-infective Drugs
Last Funding Date: 2019
Investors Number: 1
Industry: Biotechnology, Pharmaceutical